Illuminating pathways and balancing precision: maximizing economic value in breast cancer gene therapy through integrated CMC, analytics, and collaboration

Arya Bhushan , Preeti Misra

10 September 2024

Commentary

Combining best practices and analytical reference materials to tackle challenges in AAV manufacturing

Mark Verdecia

03 April 2024

Commentary

Key considerations & challenges in developing flow cytometry assays for cell & gene therapy products

Ajit Kamath

12 December 2022

Commentary

Outcomes from a cell viability workshop: fit-for-purpose considerations for cell viability measurements for cellular therapeutic products

L Pierce, S Sarkar, L Li-Ying Chan et al

14 May 2021

Commentary

Finding quality in complexity: how cellular therapeutics are shifting analytical paradigms for clinical supply and product manufacturing

Vilma Jimenez Sabinina, Dominic Günter Hildebrand

13 May 2021

Commentary

Master ATMP processes by controlling raw and starting material

Anne-Sophie Lebrun, Carmen Brenner

24 March 2021

Commentary

Considerations for performing virtual quality audits on manufacturers of gene therapy viral vectors: an auditor’s perspective during the COVID-19 public health emergency

Gary C du Moulin, PhD, MPH, RAC

18 March 2021

Commentary

The right analytical toolbox is key to moving your pipeline forward

Andrew Espejo

25 August 2020

Commentary

Analytical Technology Used in the Latest Development of Gene Therapy Candidates

Z Li, Z Wu, T Maekawa et al

16 May 2019

Commentary